Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1994 1
1995 1
1996 1
1997 1
1998 1
1999 2
2001 2
2002 2
2003 1
2006 1
2007 4
2008 7
2009 13
2010 12
2011 12
2012 11
2013 11
2014 11
2015 8
2016 5
2017 14
2018 15
2019 17
2020 22
2021 19
2022 24
2023 20
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice.
Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, Sanduzzi A, Matucci A, Prignano F, Conversano M, Goletti D; SAFEBIO (Italian multidisciplinary task force for screening of tuberculosis before and during biologic therapy). Cantini F, et al. Among authors: prignano f. Autoimmun Rev. 2015 Jun;14(6):503-9. doi: 10.1016/j.autrev.2015.01.011. Epub 2015 Jan 21. Autoimmun Rev. 2015. PMID: 25617816 Free article. Review.
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis.
Gisondi P, Fargnoli MC, Amerio P, Argenziano G, Bardazzi F, Bianchi L, Chiricozzi A, Conti A, Corazza M, Costanzo A, Dapavo P, DE Simone C, Fabbrocini G, Feliciani C, Foti C, Girolomoni G, Guarneri C, Marzano AV, Micali G, Offidani A, Parodi A, Pellacani G, Piaserico S, Prignano F, Romanelli M, Rongioletti F, Rubegni P, Stinco G, Stingeni L, Tomasini CF, Venturini M, Peris K, Calzavara-Pinton P. Gisondi P, et al. Among authors: prignano f. Ital J Dermatol Venerol. 2022 Feb;157(Suppl. 1 to No. 1):1-78. doi: 10.23736/S2784-8671.21.07132-2. Ital J Dermatol Venerol. 2022. PMID: 35262308 Free article.
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study.
Torres T, Puig L, Vender R, Yeung J, Carrascosa JM, Piaserico S, Gisondi P, Lynde C, Ferreira P, Bastos PM, Dauden E, Leite L, Valerio J, Del Alcázar-Viladomiu E, Rull EV, Llamas-Velasco M, Pirro F, Messina F, Bruni M, Licata G, Ricceri F, Nidegger A, Hugo J, Mufti A, Daponte AI, Teixeira L, Balato A, Romanelli M, Prignano F, Gkalpakiotis S, Conrad C, Lazaridou E, Rompoti N, Papoutsaki M, Nogueira M, Chiricozzi A. Torres T, et al. Among authors: prignano f. Am J Clin Dermatol. 2022 Nov;23(6):891-904. doi: 10.1007/s40257-022-00722-y. Epub 2022 Aug 17. Am J Clin Dermatol. 2022. PMID: 35976568
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.
Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Marzano AV, et al. Among authors: prignano f. Br J Dermatol. 2021 Jan;184(1):133-140. doi: 10.1111/bjd.18983. Epub 2020 Apr 13. Br J Dermatol. 2021. PMID: 32119111 Free article.
Hidradenitis suppurativa and associated diseases.
Pescitelli L, Ricceri F, Prignano F. Pescitelli L, et al. Among authors: prignano f. G Ital Dermatol Venereol. 2018 Jun;153(3 Suppl 2):8-17. doi: 10.23736/S0392-0488.17.05772-8. G Ital Dermatol Venereol. 2018. PMID: 30468375 Review.
Editorial: The immunobiology of the skin in response to the environment.
Donetti E, Sommariva M, Chiricozzi A, Prignano F. Donetti E, et al. Among authors: prignano f. Front Immunol. 2023 May 22;14:1220335. doi: 10.3389/fimmu.2023.1220335. eCollection 2023. Front Immunol. 2023. PMID: 37283764 Free PMC article. No abstract available.
Insights into the Pathogenesis of HS and Therapeutical Approaches.
Rosi E, Fastame MT, Scandagli I, Di Cesare A, Ricceri F, Pimpinelli N, Prignano F. Rosi E, et al. Among authors: prignano f. Biomedicines. 2021 Sep 6;9(9):1168. doi: 10.3390/biomedicines9091168. Biomedicines. 2021. PMID: 34572354 Free PMC article. Review.
Therapy of PsO in Special Subsets of Patients.
Di Cesare A, Ricceri F, Rosi E, Fastame MT, Prignano F. Di Cesare A, et al. Among authors: prignano f. Biomedicines. 2022 Nov 10;10(11):2879. doi: 10.3390/biomedicines10112879. Biomedicines. 2022. PMID: 36359399 Free PMC article. Review.
Tuberculosis reactivation risk in dermatology.
Pescitelli L, Ricceri F, Prignano F. Pescitelli L, et al. Among authors: prignano f. J Rheumatol Suppl. 2014 May;91:65-70. doi: 10.3899/jrheum.140104. J Rheumatol Suppl. 2014. PMID: 24789002 Review.
205 results